Apothecary Capital is an Illinois-based venture capital firm that provides financial advisory services.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 1, 2008
Portola Pharmaceuticals
|
Series C | $60.09M | Biopharma | — |
May 19, 2008
Kythera Biopharmaceuticals
|
Series C | $30M | Biopharma | — |
Dec 21, 2007
Cogentus Pharmaceuticals
|
Series C | $62.50M | Biotechnology | — |
Jan 8, 2007
Calypso Medical
|
Series D | $42.20M | Health Care | Yes |
Feb 17, 2005
FibroGen
|
Series Unknown | $100M | Biopharma | — |
Apothecary Capital has had 4 exits. Apothecary Capital most notable exits include FibroGen , Portola Pharmaceuticals
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Nov 21, 2014 | FibroGen | IPO | Biopharma | Detail |
May 23, 2013 | Portola Pharmaceuticals | M&A | Biopharma | Detail |
Oct 11, 2012 | Kythera Biopharmaceuticals | M&A | Biopharma | Detail |
Sep 19, 2011 | Calypso Medical | M&A | Health Care | Detail |